Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Introducing the "PharmTech AI Pulse Check" Expert Video Series
2
PharmTech Weekly Roundup—September 18, 2026
3
Can AI Agents Satisfy CGMP Documentation Requirements?
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5